NCT05177588View on ClinicalTrials.gov

Efficacy of Metformin as add-on Therapy in Non-Diabetic Heart Failure Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

July 21, 2021

Primary Completion Date

March 30, 2023

Study Completion Date

April 30, 2023

Conditions
Heart Failure
Interventions
DRUG

Metformin Hydrochloride

Metformin 2000 mg/day

Trial Locations (1)

12566

Agouza Hospital, Giza

All Listed Sponsors
lead

Cairo University

OTHER

NCT05177588 - Efficacy of Metformin as add-on Therapy in Non-Diabetic Heart Failure Patients | Biotech Hunter | Biotech Hunter